3
|
Zhou A, Ryan J. Biological Embedding of Early-Life Adversity and a Scoping Review of the Evidence for Intergenerational Epigenetic Transmission of Stress and Trauma in Humans. Genes (Basel) 2023; 14:1639. [PMID: 37628690 PMCID: PMC10454883 DOI: 10.3390/genes14081639] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 08/14/2023] [Accepted: 08/17/2023] [Indexed: 08/27/2023] Open
Abstract
Severe or chronic stress and trauma can have a detrimental impact on health. Evidence suggests that early-life adversity can become biologically embedded and has the potential to influence health outcomes decades later. Epigenetics is one mechanism that has been implicated in these long-lasting effects. Observational studies in humans indicate that the effects of stress could even persist across generations, although whether or not epigenetic mechanisms are involved remains under debate. Here, we provide an overview of studies in animals and humans that demonstrate the effects of early-life stress on DNA methylation, one of the most widely studied epigenetic mechanisms, and summarize findings from animal models demonstrating the involvement of epigenetics in the transmission of stress across generations. We then describe the results of a scoping review to determine the extent to which the terms intergenerational or transgenerational have been used in human studies investigating the transmission of trauma and stress via epigenetic mechanisms. We end with a discussion of key areas for future research to advance understanding of the role of epigenetics in the legacy effects of stress and trauma.
Collapse
Affiliation(s)
- Aoshuang Zhou
- Division of Epidemiology, Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR, China
| | - Joanne Ryan
- School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia
| |
Collapse
|
4
|
Musanabaganwa C, Jansen S, Wani A, Rugamba A, Mutabaruka J, Rutembesa E, Uwineza A, Fatumo S, Hermans EJ, Souopgui J, Wildman DE, Uddin M, Roozendaal B, Njemini R, Mutesa L. Community engagement in epigenomic and neurocognitive research on post-traumatic stress disorder in Rwandans exposed to the 1994 genocide against the Tutsi: lessons learned. Epigenomics 2022; 14:887-895. [PMID: 36004496 PMCID: PMC9475497 DOI: 10.2217/epi-2022-0079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Epigenomic and neurocognitive studies have provided new perspectives on post-traumatic stress disorder and its intergenerational transmission. This article outlines the lessons learned from community engagement (CE) in such research on Rwandan genocide survivors. A strong trauma-related response was observed within the research project-targeted community (genocide survivors) during explanation of the project. CE also revealed privacy concerns, as community members worried that any leakage of genetic/(epi)genomic data could affect not only themselves but also their close relatives. Adopting a culture of CE in the process of research implementation enables the prioritization of targeted community needs and interests. Furthermore, CE has stimulated the development of mental healthcare interventions, which married couples can apply to protect their offspring and thus truly break the cycle of inherited vulnerability.
Collapse
Affiliation(s)
- Clarisse Musanabaganwa
- Center for Human Genetics, College of Medicine & Health Sciences, University of Rwanda, Kigali, PO BOX 4285, Rwanda.,Department of Clinical Psychology, College of Medicine & Health Sciences, University of Rwanda, PO BOX 4285, Rwanda.,Genomics Program, College of Public Health, University of South Florida, FL 33612, USA.,Department of Cognitive Neuroscience, Radboud University Medical Center, 6500HB, Nijmegen, and Donders Institute for Brain, Cognition & Behaviour, Radboud University, Nijmegen, 6525EN, The Netherlands.,Frailty in Ageing Research Department, Vrije Universiteit Brussel, Jette Campus, 1090, Belgium
| | - Stefan Jansen
- Department of Clinical Psychology, College of Medicine & Health Sciences, University of Rwanda, PO BOX 4285, Rwanda.,Directorate of Research & Innovation, College of Medicine & Health Sciences, University of Rwanda, Kigali, PO-BOX 4285, Rwanda
| | - Agaz Wani
- Genomics Program, College of Public Health, University of South Florida, FL 33612, USA
| | - Alex Rugamba
- Center for Human Genetics, College of Medicine & Health Sciences, University of Rwanda, Kigali, PO BOX 4285, Rwanda
| | - Jean Mutabaruka
- Department of Clinical Psychology, College of Medicine & Health Sciences, University of Rwanda, PO BOX 4285, Rwanda
| | - Eugene Rutembesa
- Department of Clinical Psychology, College of Medicine & Health Sciences, University of Rwanda, PO BOX 4285, Rwanda
| | - Annette Uwineza
- Center for Human Genetics, College of Medicine & Health Sciences, University of Rwanda, Kigali, PO BOX 4285, Rwanda
| | - Segun Fatumo
- London School of Hygiene & Tropical Medicine, Bloomsbury, London, WC1E 7HT, UK.,The African Computational Genomics (TACG) Research Group, MRC/UVRI & LSHTM, Entebbe, 31302, Uganda
| | - Erno J Hermans
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6500HB, Nijmegen, and Donders Institute for Brain, Cognition & Behaviour, Radboud University, Nijmegen, 6525EN, The Netherlands
| | - Jacob Souopgui
- Department of Molecular Biology, Institute of Biology & Molecular Medicine (IBMM), Université Libre de Bruxelles, Gosselies Campus, Gosselies, 126040, Belgium
| | - Derek E Wildman
- Genomics Program, College of Public Health, University of South Florida, FL 33612, USA
| | - Monica Uddin
- Genomics Program, College of Public Health, University of South Florida, FL 33612, USA
| | - Benno Roozendaal
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6500HB, Nijmegen, and Donders Institute for Brain, Cognition & Behaviour, Radboud University, Nijmegen, 6525EN, The Netherlands
| | - Rose Njemini
- Frailty in Ageing Research Department, Vrije Universiteit Brussel, Jette Campus, 1090, Belgium
| | - Leon Mutesa
- Center for Human Genetics, College of Medicine & Health Sciences, University of Rwanda, Kigali, PO BOX 4285, Rwanda
| |
Collapse
|
5
|
Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder. Psychopharmacology (Berl) 2022; 239:2515-2523. [PMID: 35438303 DOI: 10.1007/s00213-022-06141-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Accepted: 04/02/2022] [Indexed: 10/18/2022]
Abstract
Serotonin (5-HT) is implicated in the reward processes underlying substance use disorder. Epigenetic and transcriptional mechanisms contribute to the development of addictive states. To examine the potential mechanisms of 5-HT receptor genes in opioid use disorder, we first determined the associations between several single-nucleotide polymorphism (SNPs) in three representative 5-HT receptor genes (HTR1B, HTR2A, and HTR3B) and susceptibility to heroin use disorder in 1731 participants. Gene-gene interactions among these genes were analyzed. After identifying the susceptibility genes and SNPs for heroin use disorder, DNA methylation in the promoter region of these susceptibility genes was compared between 111 healthy controls and 120 patients with heroin use disorder. In addition, associations between the susceptibility SNPs and methylation of the CpG sites and gene promoters with differential methylation between groups were examined. Finally, the function of the susceptibility SNPs in the expression of the corresponding genes was screened. Our results demonstrated that rs6296 in the HTR1B gene was correlated with susceptibility to heroin use disorder. Gene-gene interactions between the HTR1B and HTR2A genes were identified. The CpG sites HTR1B_07 and HTR1B_26 and the promoter region of the HTR1B gene were hypermethylated in patients with heroin use disorder compared with healthy controls. Notably, rs6296 correlated in an allele-specific manner with methylation in the HTR1B gene promoter in the blood and gene expression of the HTR1B gene in the frontal cortex and hypothalamus. SNP rs6296 was associated with opioid use disorder by involving mechanisms of DNA methylation and expression of the HTR1B gene.
Collapse
|